The Pfizer BioNTech vaccine BNT162b2 is likely to be effective against the B1.1.7 variant of SARS-CoV-2, even though its efficacy
Pfizer BioNTech vaccine likely to be effective against B1.1.7 strain of SARS-CoV-2

besthealthtale.com
Home ยป
The Pfizer BioNTech vaccine BNT162b2 is likely to be effective against the B1.1.7 variant of SARS-CoV-2, even though its efficacy